Keith W. Muir

28.7k total citations · 4 hit papers
233 papers, 10.9k citations indexed

About

Keith W. Muir is a scholar working on Epidemiology, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Keith W. Muir has authored 233 papers receiving a total of 10.9k indexed citations (citations by other indexed papers that have themselves been cited), including 176 papers in Epidemiology, 95 papers in Neurology and 80 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Keith W. Muir's work include Acute Ischemic Stroke Management (174 papers), Cerebrovascular and Carotid Artery Diseases (77 papers) and Stroke Rehabilitation and Recovery (48 papers). Keith W. Muir is often cited by papers focused on Acute Ischemic Stroke Management (174 papers), Cerebrovascular and Carotid Artery Diseases (77 papers) and Stroke Rehabilitation and Recovery (48 papers). Keith W. Muir collaborates with scholars based in United Kingdom, United States and Australia. Keith W. Muir's co-authors include Kennedy R. Lees, E Tilling, Salwa El Tawil, Christopher J. Weir, I Bone, Lindsay Wilson, Asha Hareendran, Fiona Moreton, Tracey Baird and Joanna M. Wardlaw and has published in prestigious journals such as The Lancet, Circulation and Nature Communications.

In The Last Decade

Keith W. Muir

224 papers receiving 10.5k citations

Hit Papers

Do Clinicians Overestimat... 2002 2026 2010 2018 2019 2002 2009 2018 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keith W. Muir United Kingdom 47 6.7k 3.5k 3.3k 2.2k 1.5k 233 10.9k
Marc Ribó Spain 57 7.5k 1.1× 3.9k 1.1× 3.8k 1.2× 1.9k 0.8× 1.1k 0.7× 304 10.6k
Turgut Tatlisumak Finland 58 6.1k 0.9× 2.8k 0.8× 4.3k 1.3× 1.7k 0.8× 2.0k 1.3× 314 12.3k
Carlos A. Molina Spain 59 8.8k 1.3× 5.1k 1.5× 4.3k 1.3× 2.0k 0.9× 1.1k 0.7× 213 12.4k
José Álvarez‐Sabín Spain 65 7.9k 1.2× 4.3k 1.2× 4.6k 1.4× 1.5k 0.7× 1.9k 1.3× 250 13.2k
Ashfaq Shuaib Canada 58 6.6k 1.0× 3.4k 1.0× 4.0k 1.2× 1.6k 0.7× 2.3k 1.5× 472 14.4k
Kazumi Kimura Japan 45 5.8k 0.9× 3.3k 1.0× 2.8k 0.9× 1.5k 0.7× 723 0.5× 459 9.7k
Oh Young Bang South Korea 57 5.1k 0.8× 4.2k 1.2× 3.7k 1.1× 1.1k 0.5× 1.6k 1.0× 308 12.9k
Dietmar Schneider Germany 32 7.7k 1.2× 3.3k 1.0× 3.7k 1.1× 2.6k 1.2× 1.2k 0.8× 74 10.4k
Sidney Starkman United States 56 10.1k 1.5× 5.4k 1.6× 5.7k 1.7× 2.7k 1.2× 1.1k 0.7× 212 13.9k
Askiel Bruno United States 35 7.5k 1.1× 3.3k 1.0× 3.2k 1.0× 2.3k 1.1× 991 0.6× 109 10.8k

Countries citing papers authored by Keith W. Muir

Since Specialization
Citations

This map shows the geographic impact of Keith W. Muir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith W. Muir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith W. Muir more than expected).

Fields of papers citing papers by Keith W. Muir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith W. Muir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith W. Muir. The network helps show where Keith W. Muir may publish in the future.

Co-authorship network of co-authors of Keith W. Muir

This figure shows the co-authorship network connecting the top 25 collaborators of Keith W. Muir. A scholar is included among the top collaborators of Keith W. Muir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith W. Muir. Keith W. Muir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ospel, Johanna M., Kazutaka Uchida, Andrew M. Demchuk, et al.. (2025). Modified Rankin Scale at 90 Days Versus National Institutes of Health Stroke Scale at 24 Hours as Primary Outcome in Acute Stroke Trials. Journal of the American Heart Association. 14(5). e037752–e037752. 1 indexed citations
2.
Stone, Christopher, et al.. (2025). Sex-Specific Improvements in Myocardial Function and Angiogenesis with SGLT-2 Inhibitor Canagliflozin in a Swine Model of Metabolic Syndrome. International Journal of Molecular Sciences. 26(5). 1887–1887. 1 indexed citations
4.
Schiphorst, Adrien ter, Pierre Seners, Caroline Arquizan, et al.. (2025). The Large Core Paradox. Stroke. 56(9). 2786–2797.
5.
Muir, Keith W.. (2024). Should we switch to tenecteplase for all ischemic strokes? Evidence and logistics. International Journal of Stroke. 20(3). 261–267. 1 indexed citations
6.
Woodward, Rosemary, et al.. (2024). Towards clinical translation of 7 Tesla MRI in the human brain. SHILAP Revista de lepidopterología. 9. 100025–100025. 3 indexed citations
7.
Tanaka, Kõji, Scott Brown, Mayank Goyal, et al.. (2024). HERMES-24 Score Derivation and Validation for Simple and Robust Outcome Prediction After Large Vessel Occlusion Treatment. Stroke. 55(8). 1982–1990. 1 indexed citations
8.
Singh, Nishita, Carol Kenney, Kenneth Butcher, et al.. (2024). A Randomized Controlled Trial of Tenecteplase Versus Standard of Care for Minor Ischemic Stroke with Proven Occlusion (TEMPO-2): Rational and design of a multicenter, randomized open-label clinical trial. International Journal of Stroke. 19(7). 817–822. 1 indexed citations
9.
Parry‐Jones, Adrian, Katie Stocking, Mary Joan MacLeod, et al.. (2023). Phase II randomised, placebo-controlled, clinical trial of interleukin-1 receptor antagonist in intracerebral haemorrhage: BLOcking the Cytokine IL-1 in ICH (BLOC-ICH). European Stroke Journal. 8(3). 819–827. 15 indexed citations
10.
Ospel, Johanna M., Scott Brown, Rosalie McDonough, et al.. (2023). Endovascular therapy in acute ischemic stroke with poor reperfusion is associated with worse outcomes compared with best medical management: a HERMES substudy. Journal of NeuroInterventional Surgery. 16(9). 878–883. 6 indexed citations
12.
Schwarz, Ghil, Gargi Banerjee, Isabel C. Hostettler, et al.. (2022). MRI and CT imaging biomarkers of cerebral amyloid angiopathy in lobar intracerebral hemorrhage. International Journal of Stroke. 18(1). 85–94. 16 indexed citations
13.
Wouters, Anke, Patrick Dupont, Florent Boutitie, et al.. (2022). Sex differences in imaging and clinical characteristics of patients from the WAKE‐UP trial. European Journal of Neurology. 30(3). 641–647. 1 indexed citations
14.
Cheng, Bastian, Hans O. Pinnschmidt, Eckhard Schlemm, et al.. (2021). Estimating nocturnal stroke onset times by magnetic resonance imaging in the WAKE-UP trial. International Journal of Stroke. 17(3). 323–330. 3 indexed citations
15.
Hurford, Robert, et al.. (2020). Diagnosis and management of acute ischaemic stroke. Practical Neurology. 20(4). 304–316. 112 indexed citations
16.
Jensen, Märit, Eckhard Schlemm, Bastian Cheng, et al.. (2020). Clinical Characteristics and Outcome of Patients With Hemorrhagic Transformation After Intravenous Thrombolysis in the WAKE-UP Trial. Frontiers in Neurology. 11. 957–957. 19 indexed citations
17.
Almekhlafi, Mohammed, Michael D. Hill, Bruce Campbell, et al.. (2019). Stroke Laterality Did Not Modify Outcomes in the HERMES Meta-Analysis of Individual Patient Data of 7 Trials. Stroke. 50(8). 2118–2124. 17 indexed citations
18.
Damion, Robin A., Michael J. Knight, Rose Bosnell, et al.. (2019). Quantifying T 2 relaxation time changes within lesions defined by apparent diffusion coefficient in grey and white matter in acute stroke patients. Physics in Medicine and Biology. 64(9). 95016–95016. 3 indexed citations
19.
Østergaard, Leif, Thorbjørn S Engedal, Fiona Moreton, et al.. (2015). Cerebral small vessel disease: Capillary pathways to stroke and cognitive decline. Journal of Cerebral Blood Flow & Metabolism. 36(2). 302–325. 210 indexed citations
20.
Muir, Keith W., Michael McCormick, Tracey Baird, & Myzoon Ali. (2011). Prevalence, predictors and prognosis of post-stroke hyperglycaemia in acute stroke trials: individual patient data pooled analysis from the virtual international stroke trials archive (VISTA). Cerebrovascular Diseases. 1(1). 17–27. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026